H2 inhibits TNF-α-induced lectin-like oxidized LDL receptor-1 expression by inhibiting nuclear factor κB activation in endothelial cells
Song Guohua, Tian Hua, Liu Jia, Zhang Hongle, Sun Xuejun, Qin Shucun · Biotechnology Letters · 2011
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
Molecular hydrogen produced a favorable primary result in this animal study, supporting further research into its potential for cancer and supportive oncology research.
Molecular hydrogen cancer supportive study 2011 guohua: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. H(2) is a therapeutic antioxidant that can reduce oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them). Oxidized low-density lipoprotein, which plays roles in atherosclerosis, may promote endothelial dysfunction (impaired function of the inner lining of blood vessels) by binding the cell-surface receptor LOX-1. LOX-1 expression can be upregulated by various stimuli, including TNF-α.
Publication: Song Guohua, Tian Hua, Liu Jia, Zhang Hongle, Sun Xuejun, Qin Shucun, Biotechnology Letters, 2011.
What the researchers studied
Thus, we aimed to examine whether the upregulation of LOX-1 by different stimuli could be blocked by H(2) in endothelial cells.
What effects did molecular hydrogen have?
Observed hydrogen effects: H(2) is a therapeutic antioxidant that can reduce oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them). H(2) significantly abolished the upregulation of LOX-1 by different stimuli, including TNF-α, at the protein and mRNA levels.
Why these findings matter
The result supports the biological and therapeutic potential of molecular hydrogen for cancer and supportive oncology research. It shows that hydrogen affected meaningful outcomes in an animal model, but it does not prove that the same benefit will occur in people.
How strong is this evidence?
This is preclinical animal evidence. It can show biological effects in a whole living system, but human effectiveness and dosing still require clinical trials.
Technical study details
- Publication type: Animal study
- Evidence type: Preclinical animal evidence
- Research model or population: Mouse model
- Hydrogen method: Other or not reported
Limitations and safety
Important limitations: Preclinical animal findings may not translate directly to human outcomes.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.